Advences in the study of hypercholesterolemia and hypertriglyceridemia level in a population residing in the north-eastern region of Algeria.
DOI:
https://doi.org/10.22399/ijcesen.4786Keywords:
Dyslipidemia, Prevalence, Gender, Cholesterol, Laboratory, SurveyAbstract
Dyslipidaemia is a major public health concern worldwide. No data have been conducted in the north-eastern region of Algeria.
The aim is to determine the prevalence of hypercholesterolemia and triglyceridemia by age group and gender.
This descriptive, cross-sectional study used biochemical analysis reports from two private laboratories between December 2023 and December 2024. The medical records included lipid profile parameters such as total cholesterol (TC) and triglycerides (TG).
The study population consisted of 3000 participants, 1051 (35%) of whom were men and 1949 (65%) of whom were women. The mean age of the men was 51,82 ± 14,97, while the mean age of the women was 53,99 ± 15,59. In this study, our population was divided into two age groups: Under 40 years (n = 615; 20.5%) and over 40 years (n = 2385; 79,5%). Dyslipidaemia was defined as having a total cholesterol level of more than or equal to 2 g/L (5,2 mmol/L) and triglyceride levels of more than or equal to 1,5 g/L (1,7 mmol/L).The mean total cholesterol level was higher in women (1,76 ± 0,43 g/L) than in men (1,52 ± 0,39 g/L) (p < 0.001). A normal total cholesterol level was significantly more common in women than in men (87,6% vs 72,3%, p<0.001). The mean triglyceride level was higher in men (1,44 ± 1,04 g/L) than in women (1,28 ± 0,72 g/L). Only 67,9 % of men and 71,3% of women had normal triglyceride levels (p < 0,001). Hypercholesterolemia was present in 12,4% (130/1051) of males and 27,7% (539/1949) of females (p = 0,15). Hypertriglyceridemia had a prevalence of 32,1% (337/1051) and 28,7% (560/1449) in males and females, respectively (p < 0.001). Our research has revealed that hypertriglyceridemia is highly prevalent in the study area, constituting a significant health concern associated with factors such as age and gender.
References
[1] Yuan S., Tang B., Zheng J., & Susanna C. L. (2020). Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke. Annal of Neurology, 88, 1229-1236. DOI: https://doi.org/10.1002/ana.25916
[2] Ben Hdia Z., Ben Abdelaziz A., Melki S., Ben Hassine D., Ben Rejeb, N., Omezzine, A,, Bouslama, A., & Ben Abdelaziz, A. (2022). Epidemiology of dyslipidemia in Tunisia, HSHS study (Hammam Sousse Sahloul Heart Study). La Tunisie Medicale, 100 (04), 323-334.
[3] Cheng, H.S.H., Tan, W.R., Low, Z.S., Marvalim, C.H., Lee, J.Y.H., & Tan, N.S. Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. (2019). International Journal of Molecual Sciences, 20 (20), 2-69. 5055; https://doi.org/10.3390/ijms20205055. DOI: https://doi.org/10.3390/ijms20205055
[4] Iyengar, S. S., Narasingan, S.N., Jaipuriar, N., Mahilmaran, A., Patil, S., Abhyankar, V., & Revankar, S. (2022). Risk factors, comorbidities and Atherogenic dyslipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: real young (dyslipidaemia) study. Journal of Family Medicine and Primary, (8): 4156-4164. DOI:10.4103/jfmpc.jfmpc_546_20. DOI: https://doi.org/10.4103/jfmpc.jfmpc_546_20
[5] Jin, E.S., Shim, J.S., Kim, S.E., Bae, J.H., Kang, S., Won, J. C., Shin, M. J., Jin, H.Y., Moon, J., Lee, H., Kim, H.C., & Jeong, I.K. (2023).Dyslipidemia Fact Sheet in South Korea. Diabetes and Metabolism Journal, 47, 632 642. https://doi.org/10.4093/dmj.2023.0135. DOI: https://doi.org/10.4093/dmj.2023.0135
[6] Ford, E.S., Mokdad, A. H., Giles, W.H., & Mensah, G.A. (2003). Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia among US Adults. Clinical Investigation and Report, 2185-21. DOI: 10.1161/01.CIR.0000066320.27195.B4. DOI: https://doi.org/10.1161/01.CIR.0000066320.27195.B4
[7] Posadas-Sánchez, R., Posadas-Romero, C., Zamora-González, J., Mendoza-Pérez, E., Cardoso-Saldaña, G., & Yamamoto-Kimura, L. (2007). Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents. Metabolism: Clinical and Experimental, 56, 1666 1672. doi:10.1016/j.metabol.2007.07.009. DOI: https://doi.org/10.1016/j.metabol.2007.07.009
[8] Abd El-Gawad, H.N., El-Baz, M., El-Deeb, A.F., & El-Shenawy, S.I. (2021). Risk factors profile of coronary artery disease among medical students at Al-Azhar University, Cairo. Journal of Recent Advances in Medicine, 3 (2), 119 130. DOI: https://doi.org/10.21608/jram.2021.104011.1146
[9] Al-maqati, T.N., Gazwani, A.M., Taha, M., Almusabi, S., Elnagi, E. A., Maawadh, R. M., Alkhalaf, F. S., Almish, M., Alqahtani, F.A., & Al Naam, Y. A. (2022). The impact of age, gender, and fasting blood glucose on the serum lipid profile at a tertiary care hospital: A retrospective study. Acta Biomedical, 93 (6), 1-6.
[10] Espírito Santo, L.R., Faria, T.O., Silva, C. S. O., Xavier, L.A., Reis, V. C., Mota, G.A., Silveira, M. F., Mill, J.G., & Baldo, M. P. (2022). Socioeconomic status and education level are associated with dyslipidemia in adults not taking lipid-lowering medication : A population-based study. International Health, 14, 346 353. Doi:10.1093/inthealth/ihz089. DOI: https://doi.org/10.1093/inthealth/ihz089
[11] Mohanraj, S., Velmurugan, G., Swaminathan, K., & Ramakrishnan, A. (2023). Prevalence and risk factors for dyslipidemia among South Indian adults : A community based-NCD study. International Journal of Diabetes in Developing Countries, .https://doi.org/10.1007/s13410-023-01202-7. DOI: https://doi.org/10.1007/s13410-023-01202-7
[12] Lu, M.Y., Lai, J.C., & Chen, S. J. (2023). Influence of Sex Differences on Serum Lipid Profiles among Habitual Coffee Drinkers : Evidence from 23,072 Taiwan Biobank Participants. Nutrients, 15, 2576, 2-10. https://doi.org/10.3390/nu15112576. DOI: https://doi.org/10.3390/nu15112576
[13] Lamine, O., Aboulkacem, S., Grira, N., Ayoub, M., Sendesni, R., El-Oudi, M., Stambouli, N., Mazigh, C., & Aouni, Z. (2018). Evaluation of Cardiovascular Risk Factors in a Young Adults Tunisian Group. Journal of Biosciences and Medicines, 6, 1-14. http://www.scirp.org/journal/jbm.
[14] Dalichaouche-Benchaoui, S., & Abadi, N. (2022). Association between Obesity and Metabolic Anomalies in a Population in Eastern Algeria. Jordan Medical Journal, 56 (3), 241-249. https://doi.org/10.35516/jmj.v56i3.361. DOI: https://doi.org/10.35516/jmj.v56i3.361
[15] Russo, G.T., Giandalia, A., Romeo, E.L., & Cucinotta, D. (2015). Gender differences in lipoprotein metabolism. Journal of Sex- and Gender-Specific Medicine, 1 (2), 58 65. DOI: https://doi.org/10.1155/2016/1615735
[16] Djiby, S., Ndiaye, A., Fall, I. D., Fall, A.W.S., Demba, D., Assane, N.M., Mané, D.I., Anna, S., Norou, D.S., Mbaye, M. N., & Sall, N.D. (2018). Frequency of Lipid Balances and Prevalence of Dyslipidemies in the Biochemistry Laboratory of the Marc Sankale Center of Dakar. International Journal of Current Microbiology and Applied Sciences, 7 (12), 3276 3282. DOI: https://doi.org/10.20546/ijcmas.2018.712.379
[17] Nurshad, A., Mitu, S., Rahanuma Raihanu, K., & Farjana, I. (2023). Prevalence and factors associated with dyslipidemia in Bangladeshi adults. PLOS ONE, 18 (1), 1-13. https://doi.org/10.1371/journal.pone.0280672. DOI: https://doi.org/10.1371/journal.pone.0280672
[18] Soudre, F.M., Kouraogo, A., Kiba, A., Da, O., Benoîte, H.M., Karama, D.N., Mano, S., Drabo, D.C., Kyetega, A., Karfo, R., Kabre, E., & Sakande, J. (2024). Prevalence of Dyslipidemia among Patients Received at the Biochemistry Unit of the
Charles de Gaulle Pediatric University Hospitalin Ouagadougou. Advances in Biological Chemistry, 14, 16-26.
[19] Aguilar-Salinas, C.A., Olaiz, G., Valles, V., Torres, J.M.R., Pérez, F.J.G., Rull, J.A., Rojas, R., Franco, A., & Sepulveda, J. (2001). High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. Journal of Lipid Research, 42 (8), 1298 1307. DOI: https://doi.org/10.1016/S0022-2275(20)31581-9
[20] Thiombiano, L.P., Mbaye, A., Sarr, S. A., Ngaide, A. A., Kane, A.B., Diao, M., Kane, A., D., & Ba, S. A. (2016). Prévalence de la dyslipidémie dans la population rurale de Guéoul (Sénégal). Annales de Cardiologie et d’Angéiologie, 65, (2), 77 80. DOI: https://doi.org/10.1016/j.ancard.2015.09.045
[21] Erem, C., Hacihasanoglu, A., Deger, O., Kocak, M., & Topbas, M. (2008). Prevalence of dyslipidemia and associated risk factors among Turkish adults : Trabzon lipid study. Endocrine, 34, 36 51. DOI: https://doi.org/10.1007/s12020-008-9100-z
[22] Cho, S.M.J., Lee, H.J., Shim, J.S., Song, B.M., & Kim, H.C. (2020). Associations between age and dyslipidemia are differed by education level : The Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort. Lipids in Health and Disease, 19 (12), 2-12. https://doi.org/10.1186/s12944-020-1189-y. DOI: https://doi.org/10.1186/s12944-020-1189-y
[23] Palmisano, B.T., Zhu, L., Eckel, R.H., & Stafford, J.M. (2008). Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism, 15, 45 55. DOI: https://doi.org/10.1016/j.molmet.2018.05.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
